Progress in treatment for Crohn's disease

American Journal of Gastroenterology

Volumn 96, Issue 3, 2001, Pages 626-627

  Brzezinski, Aaron ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; INFLIXIMAB; MESALAZINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

BONE NECROSIS; CATARACT; CROHN DISEASE; DELAYED HYPERSENSITIVITY; EDITORIAL; GROWTH RETARDATION; HUMAN; INFLAMMATION; LUPUS ERYTHEMATOSUS; METABOLIC BONE DISEASE; MOON FACE; MYOPATHY; PRIORITY JOURNAL; REMISSION;

EID: 0035068209     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02239-0     Document Type: Note

References (5)

1. Cortisone and corticotrophin in ulcerative colitis
2. The efficacy of immunosuppressive therapy in Crohn's disease. A randomized long term double blind study
3. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
4. Infliximab for the treatment of fistulas in patients with Crohn's disease